ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p288.xmlNon-Hodgkin’s Lymphomas2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p288.pdf2026-04-18Non-Hodgkin’s Lymphomashttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p277.xmlPersonalizing Medicine Through Personalized Communication: Individuality of the Patient Across Borders and Cultures2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p277.pdf2026-04-18Personalizing Medicine Through Personalized Communication: Individuality of the Patient Across Borders and Cultureshttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-pxl.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-pxl.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-pxlv.xmlErrata2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-pxlv.pdf2026-04-18Erratahttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p279.xmlDoes Adjuvant Bisphosphonate in Early Breast Cancer Modify the Natural Course of the Disease? A Meta-Analysis of Randomized Controlled Trials2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p279.pdf2026-04-18Does Adjuvant Bisphosphonate in Early Breast Cancer Modify the Natural Course of the Disease? A Meta-Analysis of Randomized Controlled Trialshttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p353.xmlGenomic Analysis of Lymphoma: Potential for Clinical Application2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p353.pdf2026-04-18Genomic Analysis of Lymphoma: Potential for Clinical Applicationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p337.xmlThe Role of Hematopoietic Stem Cell Transplant in Follicular Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p337.pdf2026-04-18The Role of Hematopoietic Stem Cell Transplant in Follicular Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p347.xmlAn Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/8/3/article-p347.pdf2026-04-18An Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma